Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-02

FDA Approved: TAMSULOSIN HYDROCHLORIDE — Supplemental Application (EXELAN PHARMACEUTICALS, INC.)

View source ↗

Summary

The FDA approved a supplemental application for tamsulosin hydrochloride (Exelan Pharmaceuticals), granting approval for changes described in the supplemental f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin hydrochloride (generic) (Tamsulosin hydrochloride)

Snippet

SUPPL AP for TAMSULOSIN HYDROCHLORIDE (TAMSULOSIN HYDROCHLORIDE)